2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
September 2nd, 2025
Version: 3
Charite University Medicine Berlin
biochemistry
bioRxiv

Slice-PASEF: Maximising Ion Utilisation in LC-MS Proteomics

Sinn, L. R.Open in Google Scholar•Szyrwiel, L.Open in Google Scholar•Grossmann, J.Open in Google Scholar•Lau, K.Open in Google Scholar•Faisst, K.Open in Google Scholar•Qin, D.Open in Google Scholar•Mutschler, F.Open in Google Scholar•Khoury, L.Open in Google Scholar•Leduc, A.Open in Google Scholar•Ralser, M.Open in Google Scholaret al.

Quantitative mass spectrometry (MS)-based proteomics has become a streamlined technology with a wide range of usage. Many emerging applications, such as single-cell proteomics, spatial proteomics of tissue sections and the profiling of low-abundant posttranslational modifications, require the analysis of minimal sample amounts and are thus constrained by the sensitivity of the workflow. Here, we present Slice-PASEF, a mass spectrometry technology that leverages trapped ion mobility separation of ions to attain the theoretical maximum of tandem MS sensitivity. We implement Slice-PASEF using a new module in our DIA-NN software and show that Slice-PASEF uniquely enables precise quantitative proteomics of low sample amounts. We further demonstrate its utility towards a range of applications, including single cell proteomics and degrader drug screens via ubiquitinomics.

Similar Papers

bioRxiv
Tue Sep 02 2025
Optimal TELSAM-Target Protein Linker Character is TargetProtein-Dependent
Fusing a variant of the sterile alpha motif domain of the human translocation ETS leukaemia protein (TELSAM) to a protein of interest has been shown to significantly enhance crystallization propensity. TELSAM is a pH-dependent, polymer-forming protein crystallization chaperone which, when covalently fused to a protein of interest, forms a stable, well-ordered crystal lattice. However, despite its ...
Pedroza Romo, M. J.
•
Moody, J. D.
•
Keliiliki, A.
•
Averett, J.
...•
Stewart, C.
bioRxiv
Tue Sep 02 2025
Sticky salts: overbinding of monovalent cations to phosphorylations in all-atom forcefields
Phosphorylation is a major post-translational modification, which is involved in the regulation of the dynamics and function of Intrinsically Disordered Proteins (IDPs). We recently characterized a phenomenon, which we termed n-Phosphate collaborations (nP-collabs), where bulk cations form stable bridges between several phosphoresidues in all-atom molecular dynamic simulations. nP-collabs were fou...
Marien, J.
•
Puyo-Fourtine, J.
•
Prevost, C.
•
Sacquin-Mora, S.
•
Duboue-Dijon, E.
bioRxiv
Tue Sep 02 2025
Slice-PASEF: Maximising Ion Utilisation in LC-MS Proteomics
Quantitative mass spectrometry (MS)-based proteomics has become a streamlined technology with a wide range of usage. Many emerging applications, such as single-cell proteomics, spatial proteomics of tissue sections and the profiling of low-abundant posttranslational modifications, require the analysis of minimal sample amounts and are thus constrained by the sensitivity of the workflow. Here, we p...
Sinn, L. R.
•
Szyrwiel, L.
•
Grossmann, J.
•
Lau, K.
...•
Demichev, V.
bioRxiv
Mon Sep 01 2025
Early Transcriptomic Signatures of Reductive Stress Cardiomyopathy Reveal Insufficient HIF-1 Signaling
Chronic activation of Nrf2-regulated antioxidant pathways can lead to a pathological condition known as reductive stress (RS). While transient Nrf2 activation confers protection against oxidative stress, its sustained stimulation may provoke maladaptive responses in high-energy-demanding organs such as the heart. In this study, we employed a cardiac-specific constitutively active Nrf2 transgenic (...
Mavillapalli, R. C.
•
Dakshina Moorthy, J.
•
Ravi, Y.
•
Namakkal-Soorappan, R.
bioRxiv
Mon Sep 01 2025
Green Synthesis of Different Zein nanoparticles Characterization and In vitro Release studies
Nanoparticle-based drug delivery has gained traction in the biomedical field, as it reduces drug susceptibility, improves bioavailability, and enhances therapeutic efficacy and drug targeting. Among the various types of nanoparticles, biopolymeric nanoparticles composed of proteins and polysaccharides offer a significant advantage in drug delivery due to their biocompatibility, biodegradability, e...
Thankappan, D. A.
•
Narayanagari, V.
•
Muttanolla, A.
•
Kanade, S.
bioRxiv
Mon Sep 01 2025
Accelerating Drug Discovery with HyperLab: An Easy-to-Use AI-Driven Platform
HyperLab, developed by HITS, is a web-based, AI-driven drug discovery platform designed to increase research efficiency for experimental drug discovery researchers. The platform features an intuitive user interface and experience (UI/UX), enabling researchers without specialized expertise in AI or computational methods to readily generate essential discovery outcomes. By employing a Structure-Base...
Lim, J.
bioRxiv
Mon Sep 01 2025
Engineering a membrane-independent human prothrombinase through parsimonious mutation of factor Xa
Background: Thrombin is generated from its precursor prothrombin by sequential cleavage at Arg320 and Arg271 by the prothrombinase complex, composed of factor (f) Xa and fVa on phospholipid (PL) membrane surfaces. The affinity of human fXa for fVa is low in the absence of PL. However, fXa orthologues from the venom of group D snakes bind to fVa with high affinity, forming an active complex without...
Ustock, F. I.
•
Huntington, J. A.
bioRxiv
Mon Sep 01 2025
Identification and functional characterization of two CXCL17 paralogs from zebrafish
C-X-C motif chemokine ligand 17 (CXCL17) and its receptor G protein-coupled receptor 25 (GPR25) have been identified as a significant pair in regulating immunity, but CXCL17 orthologs have not yet been identified from non-mammalian vertebrates. This study aimed to identify and characterize non-mammalian CXCL17 orthologs based on key features of mammalian CXCL17s, such as a C-terminal Xaa-Pro-Yaa m...
Yu, J.
•
Hu, W.-F.
•
Wang, J.-J.
•
Liu, Y.-L.
...•
Guo, Z.-Y.
bioRxiv
Mon Sep 01 2025
Membrane constraints reshape synaptotagmin recognition by botulinum neurotoxin B1
Synaptotagmins 1 and 2 (SYT1 and SYT2) are essential membrane proteins in neurotransmission, aiding in synaptic vesicle fusion. The juxtamembrane domains of both SYT1 and SYT2 are recognized by botulinum neurotoxin B1 (BoNT/B1), the agent of botulism. Current experimental models describe SYT1 and SYT2 interactions with BoNT/B1 but lack membrane insertion, which may bias the observed interactions. ...
Azzaz, F.
•
Far, O. E.
•
Fantini, J.